Sort
15,842 grants matching “pancreatic cancer”
Alcohol Reduction in Medical Illnesses:HCV as Prototype
$557,054Case Western Reserve University · R01 · FY2004 · AA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$556,932Lei Zheng · Johns Hopkins University · R01 · FY2022 · CA
Targeting B7-H3 in ovarian cancer
$556,817Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs
$556,775Sunitha Nagrath · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
$556,764Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Multi-Task MR Simulation for Abdominal Radiation Treatment Planning
$556,712Zhaoyang Fan · Cedars-Sinai Medical Center · R01 · FY2020 · EB
National Gnotobiotic Resource Center
$556,690Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P40 · FY2024 · OD
National Gnotobiotic Resource Center
$556,690Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P40 · FY2025 · OD
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
$556,553Jixin Dong · University Of Nebraska Medical Center · R01 · FY2024 · CA
Regulation and Function of Stromal Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$556,513Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
UPMC Clinical Center for the Study of Chronic Pancreatitis and Diabetes
$556,500Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · DK
Targeting MTOR signaling in pancreatic cancer
$556,470Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
Case Control Study of Pancreas Cancer in Shanghai, China
$556,385Harvey A Risch · Yale University · R01 · FY2011 · CA
IGF::OT::IGF CANCER PREVENTION BY ALPHA ENOLASE VACCINATION
$556,210Paul Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2016 · CA
ADOPTIVE CELLULAR THERAPY FOR PANCREATIC CANCER
$556,200Board Of Regents Of The University Of Nebraska · · FY2024 · Defense Health Agency
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$555,851William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
$555,711David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2014 · CA
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
$555,711David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2015 · CA
Biomolecular Recognition and Binding Mechanisms
$555,634Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Serum Proteomic Biomarkers for Colon &Pancreatic Cancer
$555,569University Of Pittsburgh At Pittsburgh · U01 · FY2004 · CA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$555,474Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2025 · CA
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$555,175Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Early Diagnosis of Pancreatic Cancer
$555,169Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2014 · CA
Targeted Glycomics and Affinity Reagents for Cancer Biomarker Development
$554,934Brian B Haab · Van Andel Research Institute · U01 · FY2012 · CA
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
$554,862Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2021 · CA